Investigation Report on Chinese Thymopentin Market, 2018-2022
Description
Thymopentin is a two-way immune-regulator, i.e. it can handle both immune hypofunction and hyperfunction. The indications include chronic hepatitis B and primary or secondary T-cell deficiencies. Thymopentin can also help treat some autoimmune diseases and tumors.
As an important active component of human thymus hormone, Thymopentin is artificially synthesized and free of allergenic protein and reaction, which significantly enhances the effect of Thymopentin as a substitute for thymosin injections. Therefore, Thymopentin is a strong performer among thymosin drugs.
In 1985, Thymopentin for Injection was launched in Italy in the trade name of "Timunox". In 1997, Hainan Zhonghe Pharmaceutical Co., Ltd. first launched Thymopentin for Injection (trade name: Hexin), China's first two-way immunomodulator of synthetic polypeptide after independent research and development. The product once played an important role in the fight against SARS in 2003. Later, other enterprises including Beijing SL Pharmaceutical Co., Ltd. were approved to produce Thymopentin. Because of a low technological barrier, there are many manufacturers and fierce competitions in the market. Thymopentin is only sold in China as a Chinese-style drug.
According to CRI, in 2017, the sales value of Thymopentin exceeded CNY 1 billion in the Chinese market dominated by Hainan Zhonghe Pharmaceutical Co., Ltd., Beijing SL Pharmaceutical Co., Ltd., Beijing Sciecure Pharmaceutical Co., Ltd. and Hybio Pharmaceutical Co., Ltd. The sales value of top 10 enterprises took up about 99% of the market. The sales value of Hainan Zhonghe ranked first with a market share over 30%.
It is expected that the Chinese Thymopentin still has large potentials to grow in the coming years.
Topics Covered:
Thymopentin is a two-way immune-regulator, i.e. it can handle both immune hypofunction and hyperfunction. The indications include chronic hepatitis B and primary or secondary T-cell deficiencies. Thymopentin can also help treat some autoimmune diseases and tumors.
As an important active component of human thymus hormone, Thymopentin is artificially synthesized and free of allergenic protein and reaction, which significantly enhances the effect of Thymopentin as a substitute for thymosin injections. Therefore, Thymopentin is a strong performer among thymosin drugs.
In 1985, Thymopentin for Injection was launched in Italy in the trade name of "Timunox". In 1997, Hainan Zhonghe Pharmaceutical Co., Ltd. first launched Thymopentin for Injection (trade name: Hexin), China's first two-way immunomodulator of synthetic polypeptide after independent research and development. The product once played an important role in the fight against SARS in 2003. Later, other enterprises including Beijing SL Pharmaceutical Co., Ltd. were approved to produce Thymopentin. Because of a low technological barrier, there are many manufacturers and fierce competitions in the market. Thymopentin is only sold in China as a Chinese-style drug.
According to CRI, in 2017, the sales value of Thymopentin exceeded CNY 1 billion in the Chinese market dominated by Hainan Zhonghe Pharmaceutical Co., Ltd., Beijing SL Pharmaceutical Co., Ltd., Beijing Sciecure Pharmaceutical Co., Ltd. and Hybio Pharmaceutical Co., Ltd. The sales value of top 10 enterprises took up about 99% of the market. The sales value of Hainan Zhonghe ranked first with a market share over 30%.
It is expected that the Chinese Thymopentin still has large potentials to grow in the coming years.
Topics Covered:
- Development of Chinese Thymopentin Market
- Size of Chinese Thymopentin Market
- Competition Pattern of Chinese Thymopentin Market
- Thymopentin Prices in Chinese Thymopentin Market
- Prospects of Chinese Thymopentin Market
1 RELEVANT CONCEPTS OF THYMOPENTIN
1.1 Indications
1.2 Development History of Thymopentin in China
2 MARKET OVERVIEW OF THYMOPENTIN IN CHINA
2.1 Governmental Approval of Thymopentin in China
2.2 Major Manufacturers
3 SALES OF THYMOPENTIN IN CHINA, 2013-2017
3.1 Sales Value of Thymopentin
3.1.1 Overall Sales Value
3.1.2 Sales Value in Different Regions
3.2 Sales Volume
3.2.1 Overall Sales Volume
3.2.2 Sales Volume in Different Regions
4 INVESTIGATION ON MARKET SHARE OF MAJOR THYMOPENTIN MANUFACTURERS IN CHINA, 2013-2017
4.1 Market Share by Sales Value
4.2 Market Share by Sales Volume
5 THYMOPENTIN IN DIFFERENT DOSAGE FORMS, 2013-2017
5.1 Market Share of Dosage Forms by Sales Value
5.2 Market Share of Dosage Forms by Sales Volume
6 REFERENCE SALE PRICE OF MAJOR THYMOPENTIN PRODUCTS IN CHINESE MARKET, 2017-2018
6.1 Hainan Zhonghe Pharmaceutical Co., Ltd. (Trade Name: Hexin)
6.2 Beijing SL Pharmaceutical Co., Ltd. (Trade Name: Ouning)
6.3 Beijing Sciecure Pharmaceutical Co., Ltd. (Trade Name: Tongda)
6.4 Wuhan Hualong Bio-pharmaceutical Co., Ltd. (Trade Name: Ruilineng)
6.5 Hybio Pharmaceutical Co., Ltd. (Trade Name: Hanning)
6.6 Sinopharm A-Think Pharmaceutical Co., Ltd. (Trade Name: Liertai)
6.7 Shanghai Huayuan Pharmacy (Ningxia) Shasai Pharmaceutical Co., Ltd. (Trade Name: Guole)
6.8 Yangtze River Pharmaceutical (Group) Co., Ltd. (Trade Name: Suwei)
6.9 Chengdu DIAO Jiuhong Pharmaceutical Factory (Trade Name: Tiboding)
6.10 Henan Furen Huaiqingtang Pharmaceutical Co., Ltd.
7 MAJOR THYMOPENTIN MANUFACTURERS IN CHINA, 2013-2017
7.1 Hainan Zhonghe Pharmaceutical Co., Ltd.
7.2 Beijing SL Pharmaceutical Co., Ltd.
7.3 Beijing Sciecure Pharmaceutical Co., Ltd.
7.4 Wuhan Hualong Bio-pharmaceutical Co., Ltd.
7.5 Hybio Pharmaceutical Co., Ltd.
7.6 Sinopharm A-Think Pharmaceutical Co., Ltd.
7.7 Shanghai Huayuan Pharmacy (Ningxia) Shasai Pharmaceutical Co., Ltd.
7.8 Yangtze River Pharmaceutical (Group) Co., Ltd.
7.9 Chengdu DIAO Jiuhong Pharmaceutical Factory
7.10 Henan Furen Huaiqingtang Pharmaceutical Co., Ltd.
8 PROSPECTS OF CHINESE THYMOPENTIN MARKET, 2018-2022
8.1 Forecast on Market Size
8.2 Forecast on Competition Pattern
1.1 Indications
1.2 Development History of Thymopentin in China
2 MARKET OVERVIEW OF THYMOPENTIN IN CHINA
2.1 Governmental Approval of Thymopentin in China
2.2 Major Manufacturers
3 SALES OF THYMOPENTIN IN CHINA, 2013-2017
3.1 Sales Value of Thymopentin
3.1.1 Overall Sales Value
3.1.2 Sales Value in Different Regions
3.2 Sales Volume
3.2.1 Overall Sales Volume
3.2.2 Sales Volume in Different Regions
4 INVESTIGATION ON MARKET SHARE OF MAJOR THYMOPENTIN MANUFACTURERS IN CHINA, 2013-2017
4.1 Market Share by Sales Value
4.2 Market Share by Sales Volume
5 THYMOPENTIN IN DIFFERENT DOSAGE FORMS, 2013-2017
5.1 Market Share of Dosage Forms by Sales Value
5.2 Market Share of Dosage Forms by Sales Volume
6 REFERENCE SALE PRICE OF MAJOR THYMOPENTIN PRODUCTS IN CHINESE MARKET, 2017-2018
6.1 Hainan Zhonghe Pharmaceutical Co., Ltd. (Trade Name: Hexin)
6.2 Beijing SL Pharmaceutical Co., Ltd. (Trade Name: Ouning)
6.3 Beijing Sciecure Pharmaceutical Co., Ltd. (Trade Name: Tongda)
6.4 Wuhan Hualong Bio-pharmaceutical Co., Ltd. (Trade Name: Ruilineng)
6.5 Hybio Pharmaceutical Co., Ltd. (Trade Name: Hanning)
6.6 Sinopharm A-Think Pharmaceutical Co., Ltd. (Trade Name: Liertai)
6.7 Shanghai Huayuan Pharmacy (Ningxia) Shasai Pharmaceutical Co., Ltd. (Trade Name: Guole)
6.8 Yangtze River Pharmaceutical (Group) Co., Ltd. (Trade Name: Suwei)
6.9 Chengdu DIAO Jiuhong Pharmaceutical Factory (Trade Name: Tiboding)
6.10 Henan Furen Huaiqingtang Pharmaceutical Co., Ltd.
7 MAJOR THYMOPENTIN MANUFACTURERS IN CHINA, 2013-2017
7.1 Hainan Zhonghe Pharmaceutical Co., Ltd.
7.2 Beijing SL Pharmaceutical Co., Ltd.
7.3 Beijing Sciecure Pharmaceutical Co., Ltd.
7.4 Wuhan Hualong Bio-pharmaceutical Co., Ltd.
7.5 Hybio Pharmaceutical Co., Ltd.
7.6 Sinopharm A-Think Pharmaceutical Co., Ltd.
7.7 Shanghai Huayuan Pharmacy (Ningxia) Shasai Pharmaceutical Co., Ltd.
7.8 Yangtze River Pharmaceutical (Group) Co., Ltd.
7.9 Chengdu DIAO Jiuhong Pharmaceutical Factory
7.10 Henan Furen Huaiqingtang Pharmaceutical Co., Ltd.
8 PROSPECTS OF CHINESE THYMOPENTIN MARKET, 2018-2022
8.1 Forecast on Market Size
8.2 Forecast on Competition Pattern
SELECTED CHARTS
Chart Governmental Approval of Thymopentin in China
Chart Sales of Thymopentin in China, 2013-2017
Chart Sales Value of Thymopentin in China, 2013- 2017
Chart Sales Value of Thymopentin in Regions of China, 2013-2017
Chart Sales Volume of Thymopentin in China, 2013- 2017
Chart Market Share and Sales Value of Hainan Zhonghe's Thymopentin in China, 2013-2017
Chart Market Share and Sales Value of Beijing SL's Thymopentin in China, 2013-2017
Chart Market Share and Sales Value of Beijing Sciecure's Thymopentin in China, 2013-2017
Chart Market Share and Sales Value of Hybio's Thymopentin in China, 2013-2017
Chart Market Share and Sales Value of Wuhan Hualong's Thymopentin in China, 2013-2017
Chart Prices of Wuhan Hualong's Thymopentin in Several Chinese Cities, 2017-2018
Chart Prices of Beijing Sciecure's Thymopentin in Several Chinese Cities, 2017-2018
Chart Prices of Beijing SL's Thymopentin in Several Chinese Cities, 2017-2018
Chart Forecast on Thymopentin's Sales in China, 2018-2022
Chart Governmental Approval of Thymopentin in China
Chart Sales of Thymopentin in China, 2013-2017
Chart Sales Value of Thymopentin in China, 2013- 2017
Chart Sales Value of Thymopentin in Regions of China, 2013-2017
Chart Sales Volume of Thymopentin in China, 2013- 2017
Chart Market Share and Sales Value of Hainan Zhonghe's Thymopentin in China, 2013-2017
Chart Market Share and Sales Value of Beijing SL's Thymopentin in China, 2013-2017
Chart Market Share and Sales Value of Beijing Sciecure's Thymopentin in China, 2013-2017
Chart Market Share and Sales Value of Hybio's Thymopentin in China, 2013-2017
Chart Market Share and Sales Value of Wuhan Hualong's Thymopentin in China, 2013-2017
Chart Prices of Wuhan Hualong's Thymopentin in Several Chinese Cities, 2017-2018
Chart Prices of Beijing Sciecure's Thymopentin in Several Chinese Cities, 2017-2018
Chart Prices of Beijing SL's Thymopentin in Several Chinese Cities, 2017-2018
Chart Forecast on Thymopentin's Sales in China, 2018-2022
